-
Innovation Ranking
Innovation Ranking – bioMerieux SA
bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents and software for the diagnosis of infectious diseases, cardiovascular diseases and cancers, besides identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers immunoassays, microbiology products, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical, and cosmetic industries; veterinary diagnostic...
-
Sector Analysis
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.41 billion in 2023 and will grow at a CAGR of more than 4% during 2023-2033. The market growth is attributed to the increasing number of immunochemistry analyzers. Immunochemistry Analyzers Market Outlook 2023-2033 ($ Billion) Buy Full Report for More Insights on the Immunochemistry Analyzers Market Forecast Download a Free Sample Report The immunochemistry analyzers market research report identifies quantitative market trends within in vitro diagnostics therapeutic...
-
Sector Analysis
Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Polymerase Chain Reaction (PCR) Systems Market Report Overview The Polymerase Chain Reaction (PCR) Systems market size was $700.3 million in 2023 and will grow at a CAGR of more than 5% from 2023 to 2033. PCR Systems are instruments used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. Polymerase Chain Reaction (PCR) Systems Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights into the Polymerase...
-
Company Insights
Innovation and Patenting activity of bioMerieux SA Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of bioMerieux SA Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Sector Analysis
Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Bordetella pertussis (Whooping Cough) Tests Market Report Overview The Bordetella pertussis (Whooping Cough) test market size was $31.7 million in 2023 and will grow at a declining CAGR of less than 1% from 2023 to 2033. Bordetella pertussis (Whooping Cough) tests are carried out to detect infections caused by the bacterium Bordetella pertussis, using a combination of molecular techniques, immunoassay, and other techniques. Bordetella pertussis (Whooping Cough) Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights...
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
COVID-19 tests Market Report Overview The COVID-19 tests market size was valued at $23.97 billion in 2023. The market will decline at a CAGR of more than 22%. COVID-19 tests are used to screen for and identify infections caused by the SARS-CoV-2- coronavirus, an emerging pathogen that was first discovered in China in the early 21st century. The COVID-19 test can be performed using point-of-care rapid testing, laboratory-based ELISA testing, or PCR. COVID-19 Tests Market Outlook 2023-2033 ($ Billion) Buy...
-
Sector Analysis
Lyme Disease Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Lyme Disease Tests Market Report Overview The Lyme disease tests market size was $11.3 million in 2023 and will grow at a CAGR of more than 6% from 2023 to 2033. Lyme disease tests are carried out to diagnose infections caused by the tick-borne bacterium Borrelia, which can result in neurological and joint diseases. Lyme Disease Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights into the Lyme Disease Tests Market Forecast, Download a Free Sample...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRAF Tests Market Report Overview The BRAF tests market size was valued at $14.2 million in 2023. Factors including increasing incidence of melanoma and colorectal and lung cancers will drive the BRAF tests market to grow at a CAGR of more than 6% during 2023-2033. Mutation testing from formalin-fixed paraffin-embedded tumor tissue is standard practice for metastatic melanoma and can be performed on multiple sample types including resected specimens, biopsies, and needle biopsies. The most important factors to ensure quality...
-
Sector Analysis
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Clostridium Difficile Tests Market Report Overview The clostridium difficile tests market size was $172.1 million in 2023. The market will decline at a CAGR of more than 1% from 2023 to 2033. Clostridium Difficile Tests are carried out to diagnose the bacterium, commonly known as C. diff, which is a major cause of serious diarrheal infections, and may also cause colon cancer. Clostridium Difficile Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights on the Clostridium...